These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 18181172

  • 1. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.
    Furlan A, Vercamer C, Desbiens X, Pourtier A.
    J Cell Physiol; 2008 Jun; 215(3):782-93. PubMed ID: 18181172
    [Abstract] [Full Text] [Related]

  • 2. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
    Jiang Y, Xu W, Lu J, He F, Yang X.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):1123-30. PubMed ID: 11527416
    [Abstract] [Full Text] [Related]

  • 3. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 4. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
    Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE.
    J Cell Biochem; 2009 Aug 15; 107(6):1168-81. PubMed ID: 19533669
    [Abstract] [Full Text] [Related]

  • 5. Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering.
    Delannoy-Courdent A, Fauquette W, Dong-Le Bourhis XF, Boilly B, Vandenbunder B, Desbiens X.
    Int J Dev Biol; 1996 Dec 15; 40(6):1097-108. PubMed ID: 9032015
    [Abstract] [Full Text] [Related]

  • 6. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA, Vargas M, Soares CR, Holzer RG, Ide AE, Jorcyk CL.
    Prostate; 2005 Jul 01; 64(2):139-48. PubMed ID: 15678502
    [Abstract] [Full Text] [Related]

  • 7. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells.
    Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S, Fujinaga K.
    Oncogene; 1996 Jan 18; 12(2):221-7. PubMed ID: 8570199
    [Abstract] [Full Text] [Related]

  • 8. Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth.
    Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F, Wernert N.
    Oncogene; 2005 Aug 11; 24(34):5384-8. PubMed ID: 15940256
    [Abstract] [Full Text] [Related]

  • 9. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 11; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
    Zou JN, Wang SZ, Yang JS, Luo XG, Xie JH, Xi T.
    Cancer Lett; 2009 Jul 18; 280(1):78-85. PubMed ID: 19321255
    [Abstract] [Full Text] [Related]

  • 12. Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
    Sahin A, Vercamer C, Kaminski A, Fuchs T, Florin A, Hahne JC, Mattot V, Pourtier-Manzanedo A, Pietsch T, Fafeur V, Wernert N.
    Int J Oncol; 2009 Feb 18; 34(2):377-89. PubMed ID: 19148472
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N, Selvamurugan N.
    J Cell Biochem; 2009 Oct 01; 108(2):408-14. PubMed ID: 19582787
    [Abstract] [Full Text] [Related]

  • 14. Defining ETS transcription regulatory networks and their contribution to breast cancer progression.
    Turner DP, Findlay VJ, Moussa O, Watson DK.
    J Cell Biochem; 2007 Oct 15; 102(3):549-59. PubMed ID: 17661355
    [Abstract] [Full Text] [Related]

  • 15. Ets-1 controls breast cancer cell balance between invasion and growth.
    Furlan A, Vercamer C, Bouali F, Damour I, Chotteau-Lelievre A, Wernert N, Desbiens X, Pourtier A.
    Int J Cancer; 2014 Nov 15; 135(10):2317-28. PubMed ID: 24706481
    [Abstract] [Full Text] [Related]

  • 16. The Sema domain of Met is necessary for receptor dimerization and activation.
    Kong-Beltran M, Stamos J, Wickramasinghe D.
    Cancer Cell; 2004 Jul 15; 6(1):75-84. PubMed ID: 15261143
    [Abstract] [Full Text] [Related]

  • 17. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
    Hata H, Kitamura T, Higashino F, Hida K, Yoshida K, Ohiro Y, Totsuka Y, Kitagawa Y, Shindoh M.
    Oncol Rep; 2008 May 15; 19(5):1093-8. PubMed ID: 18425363
    [Abstract] [Full Text] [Related]

  • 18. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.
    Berno V, Porrini D, Castiglioni F, Campiglio M, Casalini P, Pupa SM, Balsari A, Ménard S, Tagliabue E.
    Endocr Relat Cancer; 2005 Jun 15; 12(2):393-406. PubMed ID: 15947111
    [Abstract] [Full Text] [Related]

  • 19. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
    Monge M, Colas E, Doll A, Gonzalez M, Gil-Moreno A, Planaguma J, Quiles M, Arbos MA, Garcia A, Castellvi J, Llaurado M, Rigau M, Alazzouzi H, Xercavins J, Alameda F, Reventos J, Abal M.
    Cancer Res; 2007 Jul 15; 67(14):6753-9. PubMed ID: 17638886
    [Abstract] [Full Text] [Related]

  • 20. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
    Oh JH, Kim JH, Ahn HJ, Yoon JH, Yoo SC, Choi DS, Lee IS, Ryu HS, Min CK.
    Gynecol Oncol; 2009 Sep 15; 114(3):509-15. PubMed ID: 19539355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.